MX2016008045A - Biomarcadores de lipogenesis de novo y metodos de uso de los mismos. - Google Patents

Biomarcadores de lipogenesis de novo y metodos de uso de los mismos.

Info

Publication number
MX2016008045A
MX2016008045A MX2016008045A MX2016008045A MX2016008045A MX 2016008045 A MX2016008045 A MX 2016008045A MX 2016008045 A MX2016008045 A MX 2016008045A MX 2016008045 A MX2016008045 A MX 2016008045A MX 2016008045 A MX2016008045 A MX 2016008045A
Authority
MX
Mexico
Prior art keywords
methods
dnl
biomakers
same
novo lipogenesis
Prior art date
Application number
MX2016008045A
Other languages
English (en)
Spanish (es)
Inventor
M Watkins Steven
Original Assignee
Metabolon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metabolon Inc filed Critical Metabolon Inc
Publication of MX2016008045A publication Critical patent/MX2016008045A/es

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2405/00Assays, e.g. immunoassays or enzyme assays, involving lipids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/70Mechanisms involved in disease identification
    • G01N2800/7057(Intracellular) signaling and trafficking pathways
    • G01N2800/7066Metabolic pathways
    • G01N2800/7085Lipogenesis or lipolysis, e.g. fatty acid metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
MX2016008045A 2013-12-20 2014-12-18 Biomarcadores de lipogenesis de novo y metodos de uso de los mismos. MX2016008045A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361918866P 2013-12-20 2013-12-20
US201461934033P 2014-01-31 2014-01-31
PCT/US2014/071035 WO2015095451A1 (en) 2013-12-20 2014-12-18 Biomakers of de novo lipogenesis and methods using the same

Publications (1)

Publication Number Publication Date
MX2016008045A true MX2016008045A (es) 2016-10-12

Family

ID=53403674

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016008045A MX2016008045A (es) 2013-12-20 2014-12-18 Biomarcadores de lipogenesis de novo y metodos de uso de los mismos.

Country Status (9)

Country Link
US (1) US20160356798A1 (enExample)
EP (1) EP3082833B1 (enExample)
JP (1) JP6557235B2 (enExample)
AU (1) AU2014364539B2 (enExample)
CA (1) CA2933571A1 (enExample)
ES (1) ES2708807T3 (enExample)
MX (1) MX2016008045A (enExample)
SG (1) SG11201604702YA (enExample)
WO (1) WO2015095451A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105400732A (zh) * 2015-11-19 2016-03-16 南京理工大学 一种酒精性脂肪肝斑马鱼模型的构建方法
EP3468530A4 (en) 2016-06-10 2020-03-11 Clarity Cosmetics Inc. NON-COMEDOGEN FORMULA FOR HAIR AND SCALP CARE AND METHOD FOR USE
GB201614455D0 (en) 2016-08-24 2016-10-05 Univ Oxford Innovation Ltd Biomarkers
US11709169B2 (en) * 2017-02-07 2023-07-25 National Jewish Health Lipid abnormalities and association with atopic allergic diseases
WO2018183448A1 (en) * 2017-03-31 2018-10-04 Metabolon, Inc. Comprehensive and quatitative lipid and tocopherol analysis
US11642300B2 (en) 2019-05-15 2023-05-09 Johnson & Johnson Consumer Inc. Method of selecting skin treatment regimens, ingredients and compositions
US20220142560A1 (en) 2020-11-06 2022-05-12 Johnson & Johnson Consumer Inc. Microbiome and metobolome clusters to evaluate skin health

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1438420B1 (en) * 2001-09-24 2009-09-16 Lipomics Technologies, Inc. Methods of using quantitative lipid metabolome data
WO2005109006A1 (ja) * 2004-04-23 2005-11-17 Ajinomoto Co., Inc. 非アルコール性脂肪肝炎鑑別方法
US8119358B2 (en) * 2005-10-11 2012-02-21 Tethys Bioscience, Inc. Diabetes-related biomarkers and methods of use thereof
BRPI0810409A2 (pt) * 2007-04-18 2015-02-18 Thethys Bioscience Inc Biomarcadores relacionados ao diabetes e métodos de uso destes
WO2010028336A2 (en) * 2008-09-08 2010-03-11 President And Fellows Of Harvard College Fatty acid c16:1n7-palmitoleate a lipokine and biomarker for metabolic status
WO2012040318A2 (en) * 2010-09-23 2012-03-29 University Of Miami Compositions, methods and kits for detecting melanoma and margins of melanoma

Also Published As

Publication number Publication date
JP2017500567A (ja) 2017-01-05
EP3082833A4 (en) 2017-08-09
US20160356798A1 (en) 2016-12-08
SG11201604702YA (en) 2016-07-28
JP6557235B2 (ja) 2019-08-07
AU2014364539B2 (en) 2019-08-01
AU2014364539A1 (en) 2016-06-16
CA2933571A1 (en) 2015-06-25
ES2708807T3 (es) 2019-04-11
EP3082833A1 (en) 2016-10-26
EP3082833B1 (en) 2018-12-05
WO2015095451A1 (en) 2015-06-25

Similar Documents

Publication Publication Date Title
MX365061B (es) Biomarcadores relacionados a la funcion renal y metodos para usar los mismos.
ZA201600453B (en) Compositions, methods and kits for diagnosing and treating cd206 expressing cell-related disorders
EA201590027A1 (ru) Способы детекции заболеваний или состояний
IN2013MU03979A (enExample)
MX2015012733A (es) Metodos y composiciones para evaluar el estado renal usando adn libre de celulas de la orina.
WO2014031859A3 (en) Compositions and methods relating to blood-based biomarkers of breast cancer
WO2012160527A3 (en) Integrity evaluation system in an implantable hearing prosthesis
MX2020010147A (es) Metodos para predecir el riesgo de neumonia intersticial.
BR112012030587A2 (pt) métodos para diagnóstico de câncer pancreático, para identificar se um indivíduo precisa ou não de uma terapia contra câncer pancreático e para determinar se uma terapia contra câncer pancreático obtém sucesso, dispositivo para diagnóstico de câncer pancreático e uso de pelo menos um biomarcador
HK1218576A1 (zh) 结核病生物标志物及其用途
NZ716643A (en) Methods for predicting the risk of having a cardiovascular event and for monitoring the treatment of a cardiovascular event
EP3176268A4 (en) Novel biomarker for predicting sensitivity to egfr-targeting agent, and use thereof
WO2014169226A3 (en) Methods of diagnosing and treating chronic pain
WO2014145382A3 (en) Magnetoencephalography biomarkers of gaba-b agonist drug activity in autism spectrum disorders
EA201500080A1 (ru) Способ in vitro диагностирования и мониторинга рака
MX358474B (es) Biomarcadores salivales específicos para detección de riesgo, diagnóstico temprano, pronóstico y vigilancia de las enfermedades de alzheimer y de parkinson.
WO2013049152A3 (en) Methods for evaluating lung cancer status
MX2015015452A (es) Metodo y sistema para evaluar una condicion de salud.
EP3016587A4 (en) Device and methods for assessing, diagnosing, and/or monitoring heart health
WO2012154908A3 (en) Hairy cell leukemia biomarkers and methods of using same
EA201590503A1 (ru) Альфа-1-микроглобулин для применения в лечении заболеваний, связанных с митохондриями
WO2014187884A3 (en) Mirnas as non-invasive biomarkers for heart failure
MX377026B (es) Biomarcadores para la progresión de enfermedades en melanoma.
EP3082833A4 (en) Biomarkers of de novo lipogenesis and methods using the same
BR112017000490A2 (pt) componente condutor de fluxo

Legal Events

Date Code Title Description
FG Grant or registration